Results 181 to 190 of about 200,214 (356)

One-Year Outcomes After Intravenous Recombinant Tissue Plasminogen Activator for Ischemic Stroke: A Real-World Study. [PDF]

CNS Neurosci Ther
Xue R, Gong X, Huang Y, Zhong W, Jin H, Chen Z, Chen Y, Yan S, Hu H, Yuan C, Lou M.   +10 more
europepmc   +1 more source

The Intestine as a Source of Plasminogen Activator Activity

, 1971
Henry Gans, K Mori, Robert Quinlan, Dirk Richter, B. H. Tan   +4 more
openalex   +2 more sources

Fluorogenic Substrates for the Determination of Plasminogen Activators and Plasmin [PDF]

, 1977
W. Nieuwenhuizen, G. Wijngaards, E. Groeneveld   +2 more
openalex   +1 more source

Uniqueness of plasminogen activators [PDF]

Nature, 1976
Judith K. Christman, George Acs
openaire   +3 more sources

Foetal disruptive brain injuries: Diagnosing the underlying pathogenetic mechanisms with cranial ultrasonography

Developmental Medicine &Child Neurology, EarlyView.
Abstract Antenatal destructive events affecting the central nervous system of the foetus lead to disruptive brain lesions that are often associated with impaired neurodevelopment. The pathogenesis of these lesions encompasses a range of causes, including haemorrhagic, embolic, or other vascular events; exposure to teratogens, such as drugs or substance
Ana Alarcón, Nuria Carreras, Tobias Muehlbacher, Dídac Casas‐Alba, Roberta Arena, Paola Roca‐Llabrés, Juan Navarro‐Morón, Linda S. de Vries, Paul Govaert, the EurUS.Brain group, Thais Agut, Roberta Arena, Ana Alarcón, Juan Arnáez, Marco Bartocci, Isabel Benavente‐Fernández, María Carmen Bravo, Fernando Cabañas, Nuria Carreras, Olivier Claris, Jeroen Dudink, Monica Fumagalli, Alfredo García‐Alix, Paul Govaert, Sandra Horsch, Simón Lubián, Tobias Muehlbacher, Alessandro Parodi, Adelina Pellicer, Luca Ramenghi, Charles C. Roehr, Simone Schwarz, Sylke Steggerda, Eva Valverde   +33 more
wiley   +1 more source

Successful Intraluminal Administration of Tissue Plasminogen Activator for Life-Threatening Obstructive Hematoma in Extremely Preterm Infants. [PDF]

J Korean Med Sci
Kim SH, Ahn SY, Kim H, Hwang J, Yang M, Sung SI, Chang YS.   +6 more
europepmc   +1 more source

A comparison of the urokinase and streptokinase activation properties of the native and lower molecular weight forms of sheep plasminogen.

, 1979
Nicholas F. Paoni, Francis Castellino
openalex   +1 more source

Plasminogen Activator Release by Oral Contraceptives and Exercise [PDF]

, 1977
Anne M Hedlin
openalex   +1 more source

Why, how and in whom should we measure levels of lipoprotein(a): A review of the latest evidence and clinical implications

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Lipoprotein(a) [Lp(a)] is a genetically determined, causal risk factor for atherosclerotic cardiovascular disease (ASCVD) and calcific aortic valve disease (CAVD). Despite robust evidence from epidemiological and genetic studies, Lp(a) remains underrecognised in clinical practice due to challenges in measurement, lack of guideline familiarity ...
Alexander C. Razavi, Harpreet S. Bhatia, Roger S. Blumenthal, Michael D. Shapiro, Anurag Mehta   +4 more
wiley   +1 more source

Free Flap Salvage Using Extracorporeal Tissue Plasminogen Activator Administration: A Comparative Study. [PDF]

Plast Reconstr Surg Glob Open
Johansen A, Halle M, Rittri S.
europepmc   +1 more source